Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Midazolam buccal - Neuraxpharm

Next Previous
Drug Profile

Midazolam buccal - Neuraxpharm

Alternative Names: Buccolam; MHOS; Midazolam hydrochloride oromucosal solution; SHP-615; TAK-815

Latest Information Update: 13 Jan 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Therakind; ViroPharma
  • Developer Neuraxpharm; Shire; Takeda; Therakind
  • Class 3-ring heterocyclic compounds; Antiepileptic drugs; Benzodiazepines; Chlorinated hydrocarbons; Fluorobenzenes; Hypnosedatives; Imidazoles; Sleep disorder therapies; Small molecules
  • Mechanism of Action GABA A receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Epilepsy
  • New Molecular Entity No

Highest Development Phases

  • Marketed Epilepsy; Status epilepticus

Most Recent Events

  • 01 Sep 2024 CHMP of EMA recommends approval of Midazolam buccal for Epilepsy (In adults) in European Union
  • 30 Jun 2024 Preregistration for Epilepsy in Canada (Buccal)
  • 04 Oct 2022 Launched for Epilepsy (In adolescents, In children, In infants) in Switzerland (Buccal)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top